Completed PHASE2 INTERVENTIONAL NCT00481104

Evaluation of Long Term Safety of Tesofensine in Patients With Obesity

Sponsor: NeuroSearch A/S

Conditions Obesity

Interventions Tesofensine

Updated 5 times since 2017 Last updated: Jul 1, 2011 Started: May 31, 2007 Primary completion: Sep 30, 2008 Completion: Nov 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Obesity and is currently completed. NeuroSearch A/S leads this study, which shows 5 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

May 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

NeuroSearch A/S

Data source: NeuroSearch A/S

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Copenhagen, Denmark